Hi Trae, what margins do you think Cellmid would be making on this deal? I know they have said multiple times minimum 60% with Evolis; would the same threshold discipline be valid here as well?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come